AMISULPRIDE SCP amisulpride 100 mg uncoated tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

amisulpride, Quantity: 100 mg

Disponible depuis:

Southern Cross Pharma Pty Ltd

DCI (Dénomination commune internationale):

Amisulpride

forme pharmaceutique:

Tablet, uncoated

Composition:

Excipient Ingredients: magnesium stearate; lactose monohydrate; sodium starch glycollate type A; hypromellose; microcrystalline cellulose

Mode d'administration:

Oral

Unités en paquet:

30, 90, 60

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Descriptif du produit:

Visual Identification: White, round, flat tablets with diameter 9.5 mm, embossed MC on one side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2016-01-29